Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17
- PMID: 19725902
- DOI: 10.1111/j.1365-3148.2009.00946.x
Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17
Abstract
HDN attributed to the rare Rh variants has become more and more significant caused by anti-D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10-hour neonate of O, D + C + c - E - e+ blood group with severe HDN due to anti-Rh17 with least incompatible blood typed O, D + C - c + E + e-. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 micromol/L and 10.7 micromol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three-year follow-up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti-Rh17 in case that Rh17 antigen-negative blood is unavailable.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources